AvKARE recalls rosuvastatin 10 mg tablets because they failed a dissolution standard
AvKARE's rosuvastatin 10 mg tablets in 50-tablet unit dose cartons (7,991 cartons, sold nationwide) were out of specification for dissolution, meaning they did not meet the required standard.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15
- Company
- AvKARE
- Hazard
- Out of specification for dissolution.
- Units
- 7,991 5x10 cartons
- Where sold
- Nationwide in the USA
- FDA classification
- Class II · Ongoing
- Classified by FDA
- January 20, 2026
- Recall started
- December 31, 2025
- FDA enforcement report
- January 14, 2026
- Identifiers
- Codes: Lot #49124, Exp Date 12/31/2026
- FDA recall number: D-0292-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15
- Reason for recall
- Out of specification for dissolution.
- Classification
- Class II (Ongoing)
- Distribution
- Nationwide in the USA
- Quantity
- 7,991 5x10 cartons
Related recalls
AvKARE recalls amitriptyline hydrochloride tablets 10 mg because they failed dissolution specifications
The amitriptyline hydrochloride tablets, USP, 10 mg, failed dissolution specifications, and the notice covers 3534 50-count cartons sold nationwide in the US.
AvKARE · 3534 50-count cartons
AvKARE recalls Amantadine HCl capsules 100 mg over failed dissolution test
The capsules had an out-of-specification result in a dissolution test, which means they failed the dissolution specifications set for the product.
AvKARE recalls norgestimate and ethinyl estradiol tablets because they failed content uniformity specifications
The notice says these norgestimate and ethinyl estradiol tablets failed content uniformity specifications, and it covers 2192 cartons sold across the U.S.
AvKARE · 2192 cartons
Greenwich Rx recalls Glutathione Injection 10 mL vials over microbial contamination
The notice says the sterile Glutathione Injection (200 mg/mL, 10 mL multi-dose vial, Subcutaneous Only) has microbial contamination, and 4,319 vials were sent across the US.
Greenwich Rx · 4,319 vials
Pritam International recalls Brush Buddies and evo toothpastes over manufacturing practice problems
The notice says these anticavity fluoride toothpastes were made with deviations from current good manufacturing practices and were distributed across the US.
Pritam International Private Limited · 3,309,696 units
Strides Pharma recalls Cinacalcet Tablets 30 mg because they failed dissolution specifications
The 30 mg Cinacalcet Tablets in 30-count bottles failed dissolution specifications, and 49,488 bottles were distributed across the US.
Strides Pharma INC · 49,488 30-count bottles